- LCI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $51.9 million.
- LCI is down 6.1% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in LCI with the Ticky from Trade-Ideas. See the FREE profile for LCI NOW at Trade-Ideas More details on LCI: Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. LCI has a PE ratio of 17.5. Currently there are 2 analysts that rate Lannett a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Lannett has been 911,200 shares per day over the past 30 days. Lannett has a market cap of $2.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.64 and a short float of 19.6% with 6.63 days to cover. Shares are up 41.4% year-to-date as of the close of trading on Tuesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.